Agency Links:   Home  Contact Us   Help   Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

02 Testicular Lymphoma

Updated 21 February 2006

Testicular lymphoma is almost always of an aggressive histologic subtype, usually diffuse large B cell type. In contrast to other patients with localized large cell lymphoma, patients with stage 1AE or 2AE testicular lymphoma are only cured about 50% of the time using brief chemotherapy and irradiation. Thus, the recommended treatment for all stages of testicular lymphoma is a full course of chemotherapy as for advanced disease. An additional problem often seen in patients with testicular lymphoma is relapse in the opposite testicle. This can be prevented by irradiation. Finally, patients with testicular lymphoma in association with stage 3 or 4 disease are at increased risk of CNS involvement and require prophylactic intrathecal chemotherapy. The following table summarizes these recommendations by stage:

Stage Treatment
1AE, 1BE Chemotherapy* + whole scrotum radiation
2AE, 2BE Chemotherapy* + whole scrotum radiation
+ involved field nodal irradiation
3AE, 3BE, 4A, 4B Chemotherapy* + whole scrotum radiation
+ CNS chemoprophylaxis


*chemotherapy:  CHOP+rituximab


The BC Cancer Agency is a part of the Provincial Health Services Authority .
If you notice a problem with this page, please report it via the Bug Report Form.
Copyright © 2010. BC Cancer Agency. All Rights Reserved. | Terms of Use | Privacy

Unofficial document if printed. Please refer to the following web address for up-to-date information: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Lymphoma/HD/02Testicular.htm